| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANA.410300613 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410300613 |
| https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410300613 | ||
| P698 | PubMed publication ID | 1789695 |
| P50 | author | Richard E Clatterbuck | Q105982398 |
| P2093 | author name string | D. L. Price | |
| L. E. Burton | |||
| V. E. Koliatsos | |||
| H. J. Nauta | |||
| W. C. Mobley | |||
| B. Knüsel | |||
| F. F. Hefti | |||
| P2860 | cites work | Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain | Q34714755 |
| Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection | Q37410352 | ||
| Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease | Q37914845 | ||
| Potential use of nerve growth factor to treat Alzheimer's disease | Q38635096 | ||
| Neurotransmitter-related enzymes in senile dementia of the alzheimer type | Q39262591 | ||
| Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex | Q39532377 | ||
| Human beta-nerve growth factor gene sequence highly homologous to that of mouse | Q40236820 | ||
| Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat. | Q41152058 | ||
| Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. | Q41208718 | ||
| Nerve growth factor treatment after brain injury prevents neuronal death | Q41478262 | ||
| A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease | Q41540972 | ||
| Dopaminergic and cholinergic lesions in progressive supranuclear palsy | Q42205368 | ||
| Stability of numbers but not size of mouse forebrain cholinergic neurons to 53 months | Q42437373 | ||
| Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease | Q42460226 | ||
| Monoclonal antibodies to choline acetyltransferase: production, specificity, and immunohistochemistry | Q42464204 | ||
| Basal forebrain neurons in the dementia of Parkinson disease | Q42464735 | ||
| Long-term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway | Q42480532 | ||
| Trophic actions of recombinant human nerve growth factor on cultured rat embryonic CNS cells | Q42482441 | ||
| Estimation of nuclear population from microtome sections | Q82126847 | ||
| Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. | Q42482877 | ||
| Basal forebrain cell loss following fimbria/fornix transection | Q42483696 | ||
| Basal forebrain magnocellular neurons stain for nerve growth factor receptor: correlation with cholinergic cell bodies and effects of axotomy | Q42487970 | ||
| Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon | Q42493247 | ||
| Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons | Q42493454 | ||
| Localization of nerve growth factor receptor messenger RNA and protein in the adult rat brain | Q42494075 | ||
| NGF induction of NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult rat. | Q42494413 | ||
| Expression of NGF receptor in the developing and adult primate central nervous system | Q42501541 | ||
| Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): distribution, morphology, and colocalization with cholinergic enzymes | Q42502666 | ||
| Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain | Q42508891 | ||
| Age-related shrinkage of cortically projecting cholinergic neurons: a selective effect | Q42517220 | ||
| Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease | Q42519505 | ||
| Fiber pathways of basal forebrain cholinergic neurons in monkeys | Q42522218 | ||
| The cholinergic nuclei of the basal forebrain of the rat: normal structure, development and experimentally induced degeneration | Q42523346 | ||
| Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats | Q42524215 | ||
| Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons | Q42525423 | ||
| Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections | Q42525515 | ||
| Purification and amino terminal sequencing of human melanoma nerve growth factor receptor | Q42819812 | ||
| Rapid isolation of the 7S-nerve growth factor complex and its subunits from murine submaxillary glands and saliva | Q43714997 | ||
| Response of septal cholinergic neurons to axotomy | Q43803448 | ||
| Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression | Q43839045 | ||
| Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction | Q44511723 | ||
| Human beta nerve growth factor obtained from a baculovirus expression system has potent in vitro and in vivo neurotrophic activity. | Q46011936 | ||
| Morphological response of axotomized septal neurons to nerve growth factor | Q46247799 | ||
| Gracile tract degeneration in patients with sensory neuropathy and AIDS. | Q48116919 | ||
| Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor | Q48208108 | ||
| Cholinergic septal grafts into the hippocampal formation improve spatial learning and memory in aged rats by an atropine-sensitive mechanism | Q48292864 | ||
| Retrograde cell changes in medial septum and diagonal band following fimbria-fornix transection: quantitative temporal analysis | Q48301385 | ||
| Distribution of GABAergic and cholinergic neurons in the rat diagonal band | Q48381330 | ||
| Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor | Q48399039 | ||
| Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment | Q48470952 | ||
| On the chemical basis of thiocholine methods for demonstration of acetylcholinesterase activities | Q48592351 | ||
| Evidence for a ventral septal projection to the hippocampal formation of the rat. | Q48701747 | ||
| Distribution of gamma aminobutyric acid containing neurons and terminals in the septal area. An immunohistochemical study using antibodies to glutamic acid decarboxylase in the rat brain | Q48835362 | ||
| Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease | Q48859678 | ||
| Loss of true blue labelling from the medial septum following transection of the fimbria-fornix: evidence for the death of cholinergic and non-cholinergic neurons. | Q49103662 | ||
| Septal neurons containing glutamic acid decarboxylase immunoreactivity project to the hippocampal region in the rat brain. | Q50924595 | ||
| Observations on the fornix of the monkey. I. Cell studies. | Q51335097 | ||
| Degenerative Changes in Forebrain Cholinergic Nuclei Correlate with Cognitive Impairments in Aged Rats. | Q52118014 | ||
| Age differences in recognition memory of the rhesus monkey (Macaca mulatta). | Q52129083 | ||
| Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. | Q53198385 | ||
| Senile plaques in aged squirrel monkeys | Q68183887 | ||
| Nerve growth factor and Alzheimer's disease | Q68906987 | ||
| Aberrant phosphorylation of neurofilaments accompanies transmitter-related changes in rat septal neurons following transection of the fimbria-fornix | Q69189830 | ||
| Taxol produces a predominantly sensory neuropathy | Q69368435 | ||
| Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment | Q69835826 | ||
| Cells of origin of the ventral cholinergic septohippocampal pathway undergoing compensatory collateral sprouting following fimbria-fornix transection | Q71307259 | ||
| Neurotoxic effects of cisplatin therapy | Q71840491 | ||
| NGF Amplifies Expression of NGF Receptor Messenger RNA in Forebrain Cholinergic Neurons of Rats | Q74428996 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurology | Q83042 |
| P304 | page(s) | 831-840 | |
| P577 | publication date | 1991-12-01 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates | |
| P478 | volume | 30 |
| Q41051276 | 6-shogaol, a neuroactive compound of ginger (jahe gajah) induced neuritogenic activity via NGF responsive pathways in PC-12 cells |
| Q37179637 | A macrophage-nanozyme delivery system for Parkinson's disease |
| Q42458889 | A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review |
| Q42473890 | Acute application of NGF increases the firing rate of aged rat basal forebrain neurons |
| Q36554296 | Aged Non-Human Primates: An Animal Model of Age-Associated Neurodegenerative Disease |
| Q85013370 | Alzheimer disease |
| Q42521323 | Amelioration of cholinergic neurons dysfunction in aged rats depends on the continuous supply of NGF. |
| Q42498400 | Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains |
| Q48591280 | Brain-derived neurotrophic factor is reduced in Alzheimer's disease |
| Q40783837 | Cholinergic systems: human diseases, animal models, and prospects for therapy. |
| Q48559647 | Chronic intraventricular infusion with NGF improves LTP in old cognitively-impaired rats |
| Q41264952 | Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders |
| Q40670488 | Cooperative effects of gangliosides on trophic factor-induced neuronal cell recovery and synaptogenesis: studies in rodents and subhuman primates. |
| Q35664128 | Cross-linked antioxidant nanozymes for improved delivery to CNS |
| Q34458377 | Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations |
| Q28570766 | Differential alterations of NF-kappaB to oxidative stress in primary basal forebrain cultures |
| Q72033017 | Distribution of nerve growth factor following direct delivery to brain interstitium |
| Q44612858 | Effect of early thyroxine treatment on brain-derived neurotrophic factor mRNA expression and protein amount in the rat medial septum/diagonal band of Broca |
| Q40574671 | Effects of nerve growth factor in primate models of neurodegeneration: potential relevance in clinical neurology |
| Q42469886 | Evidence that nerve growth factor influences recent memory through structural changes in septohippocampal cholinergic neurons. |
| Q35602589 | Exosomes as drug delivery vehicles for Parkinson's disease therapy |
| Q38015343 | Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research |
| Q28543023 | GDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse model |
| Q39360374 | Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in the mouse with ibotenic acid-induced cognitive dysfunction |
| Q38986711 | Human olfactory bulb neural stem cells expressing hNGF restore cognitive deficit in Alzheimer's disease rat model |
| Q39437924 | Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer |
| Q49140595 | Infusion of glial maturation factor-beta reduces behavioral deficits after caudate nucleus injury in rats |
| Q52720174 | Insights on Localized and Systemic Delivery of Redox-Based Therapeutics. |
| Q48250150 | Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems |
| Q60907913 | Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates |
| Q36254749 | Lignosus rhinocerotis (Cooke) Ryvarden mimics the neuritogenic activity of nerve growth factor via MEK/ERK1/2 signaling pathway in PC-12 cells |
| Q41751967 | Localized delivery of proteins in the brain: can transport be customized? |
| Q34382945 | Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Göttingen minipig basal forebrain. |
| Q37076735 | Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery |
| Q33631069 | Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. |
| Q48001748 | Macrophages with cellular backpacks for targeted drug delivery to the brain. |
| Q38573660 | Microencapsulation of genetically engineered fibroblasts secreting nerve growth factor |
| Q35131249 | Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain |
| Q42476525 | Monoamine‐activated α2‐macroglobulin inhibits choline acetyltransferase of embryonic basal forebrain neurons and reversal of the inhibition by NGF and BDNF but not NT‐3 |
| Q36827338 | Nerve growth factor gene delivery: animal models to clinical trials |
| Q43215067 | Nerve growth factor receptor immunostaining suggests an extrinsic origin for hypertrophic nerves in Hirschsprung's disease |
| Q72596616 | Neuroblast cell death in ovo and in culture: interaction of ethanol and neurotrophic factors |
| Q40665542 | Neuropathobiology of senile dementia and mechanism of action of nootropic drugs |
| Q40779648 | Neurotrophic strategies for treating Alzheimer's disease: lessons from basic neurobiology and animal models |
| Q35117683 | Neurotrophins and Neurodegenerative Diseases: Receptors Stuck in Traffic? |
| Q40934387 | Neurotrophins and the primate central nervous system: a minireview |
| Q34074783 | Oestrogen and nerve growth factor - neuroprotection and repair in Alzheimer's disease |
| Q36582363 | On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease |
| Q35075270 | Over-expression of hNGF in adult human olfactory bulb neural stem cells promotes cell growth and oligodendrocytic differentiation. |
| Q40912774 | Pharmacology of nerve growth factor in the brain |
| Q35107162 | Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons |
| Q37263021 | Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery |
| Q52201509 | Selective effects of nerve growth factor on spatial recent memory as assessed by a delayed nonmatching-to-position task in the water maze. |
| Q38068021 | Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia |
| Q35884401 | The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor |
| Q33961288 | The cholinergic neuronal phenotype in Alzheimer's disease |
| Q52195674 | The effects of nerve growth factor on spatial recent memory in aged rats persist after discontinuation of treatment. |
| Q33264215 | The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration |
| Q34412007 | The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease |
| Q74697359 | The role of neuronal growth factors in neurodegenerative disorders of the human brain |
| Q57526641 | The treatment of Alzheimer's disease |
| Q42435326 | Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons |
| Q37610286 | Therapeutic potential of nervous system growth factors for neurodegenerative disease |
| Q48880171 | Trk receptor alterations in Alzheimer's disease. |
| Q45424062 | Young Human Cholinergic Neurons Respond to Physiological Regulators and Improve Cognitive Symptoms in an Animal Model of Alzheimer's Disease |
| Q60688389 | p75-mediated neuroprotection by NGF against glutamate cytotoxicity in cortical cultures |
Search more.